Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
First-line cetuximab + platinum-based therapy for recurrent/metastatic head and neck squamous cell carcinoma: A real-world observational study-ENCORE.
Le Tourneau C, Ghiani M, Cau MC, Depenni R, Ronzino G, Bonomo P, Montesarchio V, Leo L, Schulten J, Salmio S, Messinger D, Sbrana A, Borcoman E, Ghi MG. Le Tourneau C, et al. Among authors: depenni r. Cancer Rep (Hoboken). 2023 May;6(5):e1804. doi: 10.1002/cnr2.1804. Epub 2023 Apr 17. Cancer Rep (Hoboken). 2023. PMID: 37069784 Free PMC article.
A comparison of the antiemetic efficacy and safety of intramuscular and intravenous formulations of granisetron in patients receiving moderately emetogenic chemotherapy.
Contu A, Olmeo N, Piro S, Sabbatini R, Depenni R, Silingardi V, Zaniboni A, Meriggi F, Donati D, Maestri A, et al. Contu A, et al. Among authors: depenni r. Anticancer Drugs. 1995 Oct;6(5):652-6. doi: 10.1097/00001813-199510000-00004. Anticancer Drugs. 1995. PMID: 8845475 Clinical Trial.
Single-Cell Approaches to Profile the Response to Immune Checkpoint Inhibitors.
Gibellini L, De Biasi S, Porta C, Lo Tartaro D, Depenni R, Pellacani G, Sabbatini R, Cossarizza A. Gibellini L, et al. Among authors: depenni r. Front Immunol. 2020 Mar 20;11:490. doi: 10.3389/fimmu.2020.00490. eCollection 2020. Front Immunol. 2020. PMID: 32265933 Free PMC article. Review.
Circulating mucosal-associated invariant T cells identify patients responding to anti-PD-1 therapy.
De Biasi S, Gibellini L, Lo Tartaro D, Puccio S, Rabacchi C, Mazza EMC, Brummelman J, Williams B, Kaihara K, Forcato M, Bicciato S, Pinti M, Depenni R, Sabbatini R, Longo C, Dominici M, Pellacani G, Lugli E, Cossarizza A. De Biasi S, et al. Among authors: depenni r. Nat Commun. 2021 Mar 15;12(1):1669. doi: 10.1038/s41467-021-21928-4. Nat Commun. 2021. PMID: 33723257 Free PMC article.
Neoadjuvant treatment with single-agent cetuximab followed by 5-FU, cetuximab, and pelvic radiotherapy: a phase II study in locally advanced rectal cancer.
Bertolini F, Chiara S, Bengala C, Antognoni P, Dealis C, Zironi S, Malavasi N, Scolaro T, Depenni R, Jovic G, Sonaglio C, Rossi A, Luppi G, Conte PF. Bertolini F, et al. Among authors: depenni r. Int J Radiat Oncol Biol Phys. 2009 Feb 1;73(2):466-72. doi: 10.1016/j.ijrobp.2008.04.065. Epub 2008 Nov 10. Int J Radiat Oncol Biol Phys. 2009. PMID: 19004567 Clinical Trial.
Brain metastases: an overview.
Bertolini F, Spallanzani A, Fontana A, Depenni R, Luppi G. Bertolini F, et al. Among authors: depenni r. CNS Oncol. 2015;4(1):37-46. doi: 10.2217/cns.14.51. CNS Oncol. 2015. PMID: 25586424 Free PMC article. Review.
Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study.
Franceschi E, Depenni R, Paccapelo A, Ermani M, Faedi M, Sturiale C, Michiara M, Servadei F, Pavesi G, Urbini B, Pisanello A, Crisi G, Cavallo MA, Dazzi C, Biasini C, Bertolini F, Mucciarini C, Pasini G, Baruzzi A, Brandes AA; PERNO Study Group. Franceschi E, et al. Among authors: depenni r. J Neurooncol. 2016 May;128(1):157-162. doi: 10.1007/s11060-016-2093-1. Epub 2016 Mar 4. J Neurooncol. 2016. PMID: 26943851
65 results